Kajian terbaharu tiga dos vaksin Sinovac COVID-19 berkesan ke atas Omicron
Data penyelidikan terbaharu diterbitkan Sinovac Biotech Ltd menunjukkan bahawa tiga dos vaksin Sinovac COVID-19 menghasilkan antibodi peneutral yang lebih tinggi dalam 95 peratus penerima.
Sat Jan 22 2022
Latest research shows three doses of Sinovac vaccine effective against Omicron
New research data recently published by Sinovac Biotech Ltd shows that three doses of Sinovac COVID-19 vaccine produced higher neutralising antibodies in 95 per cent of recipients against Omicron.
Sat Jan 22 2022
Sinovac says its vaccine effective against Delta variant
Sinovac Biotech Ltd, the developer of CoronaVac COVID-19 vaccine, has defended the efficacy of its two-dose vaccine including against the Delta variant.
Fri Jul 23 2021
Sinovac vaccine contribution to Penang doubtful, company non-existent
The offer of two million doses of Sinovac vaccine by a private company for Penang is probably a sham as investigations found there is no such company.
Wed May 19 2021
Hong Kong halts Pfizer/BioNTech COVID-19 vaccines, investigates packaging
The suspension comes as the Asian financial hub has faced a sluggish take-up of vaccines due to dwindling confidence in Sinovac Biotech Ltd.
Wed Mar 24 2021
Turkey approves China-based Sinovac vaccine's emergency use
Turkish authorities gave the go-ahead for the emergency use of the COVID-19 vaccine produced by China's Sinovac Biotech Ltd.
Thu Jan 14 2021
COVID-19: Jokowi dahului vaksinasi besar-besaran Indonesia bermula 13 Jan
Penduduk Indonesia bakal menerima dos pertama COVID-19 pada 13 Januari depan dengan Presiden Joko Widodo mendapatkan suntikan pertama itu.
Tue Jan 05 2021
China to vaccinate 50 million people for Lunar New Year - SCMP
Beijing is planning to distribute 100 million doses of the vaccines made by Chinese firms Sinopharm and Sinovac Biotech Ltd.
Fri Dec 18 2020
China cari lebih banyak negara untuk ujian vaksin peringkat akhir
China National Biotec Group (CNBG) dan Sinovac Biotech Ltd. sahkan empat lagi negara bersetuju untuk menjalankan ujian klinikal peringkat akhir calon vaksin koronavirus mereka.
Sun Sep 06 2020